Be a Smart Investor
Monday, May 1, 2017
AZN Gets FDA Nod, CORT Boosts Outlook Yet Again, SNSS Withdraws Vosaroxin MAA
The FDA has granted accelerated approval to AstraZeneca plc's IMFINZI for use in previously treated patients with advanced bladder cancer.
from RTT - Biotech http://ift.tt/2qstZ6f
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment